Axonics SG&A Expenses 2017-2023 | AXNX
Axonics Annual SG&A Expenses (Millions of US $) |
|
---|---|
2023 | $235 |
2022 | $196 |
2021 | $136 |
2020 | $92 |
2019 | $68 |
2018 | $13 |
2017 | $6 |
2016 | $5 |
Axonics Quarterly SG&A Expenses (Millions of US $) |
|
---|---|
2023-12-31 | $66 |
2023-09-30 | $59 |
2023-06-30 | $55 |
2023-03-31 | $55 |
2022-12-31 | $54 |
2022-09-30 | $49 |
2022-06-30 | $50 |
2022-03-31 | $43 |
2021-12-31 | $39 |
2021-09-30 | $36 |
2021-06-30 | $33 |
2021-03-31 | $28 |
2020-12-31 | $25 |
2020-09-30 | $23 |
2020-06-30 | $20 |
2020-03-31 | $24 |
2019-12-31 | $22 |
2019-09-30 | $21 |
2019-06-30 | $15 |
2019-03-31 | $10 |
2018-12-31 | $5 |
2018-09-30 | $4 |
2018-06-30 | $2 |
2018-03-31 | $2 |
2017-12-31 | |
2017-09-30 | $1 |
2016-12-31 |
Sector | Industry | Market Cap | Revenue |
---|---|---|---|
Medical | Medical Information Systems | $3.452B | $0.366B |
Axonics Modulation Technologies Inc. is focused on development and commercialization of a novel implantable SNM system for patients with urinary and bowel dysfunction and disrupting the SNM market. Axonics Modulation Technologies Inc. is based in Irvine, CA. |
Stock Name | Country | Market Cap | PE Ratio |
---|---|---|---|
GE HealthCare Technologies (GEHC) | United States | $37.115B | 20.38 |
Inspire Medical Systems (INSP) | United States | $4.725B | 0.00 |
IRhythm Technologies (IRTC) | United States | $3.070B | 0.00 |
10x Genomics (TXG) | United States | $3.049B | 0.00 |
Hims & Hers Health (HIMS) | United States | $3.016B | 0.00 |
Olink Holding AB (publ) (OLK) | Sweden | $2.978B | 0.00 |
Enovis (ENOV) | United States | $2.863B | 21.22 |
Azenta (AZTA) | United States | $2.768B | 155.58 |
Privia Health (PRVA) | United States | $2.028B | 113.33 |
Schrodinger (SDGR) | United States | $1.664B | 0.00 |
Omnicell (OMCL) | United States | $1.454B | 50.25 |
Phreesia (PHR) | United States | $1.379B | 0.00 |
Standard BioTools (LAB) | United States | $0.725B | 0.00 |
Fulgent Genetics (FLGT) | United States | $0.673B | 0.00 |
Definitive Healthcare (DH) | United States | $0.649B | 0.00 |
Talkspace (TALK) | United States | $0.475B | 0.00 |
Clover Health Investments (CLOV) | United States | $0.464B | 0.00 |
Health Catalyst (HCAT) | United States | $0.415B | 0.00 |
Pulmonx (LUNG) | United States | $0.351B | 0.00 |
SOPHiA GENETICS SA (SOPH) | Switzerland | $0.301B | 0.00 |
Butterfly Network (BFLY) | United States | $0.213B | 0.00 |
P3 Health Partners (PIII) | United States | $0.190B | 0.00 |
Outset Medical (OM) | United States | $0.182B | 0.00 |
American Well (AMWL) | United States | $0.144B | 0.00 |
TruBridge (TBRG) | United States | $0.139B | 7.46 |
111 (YI) | China | $0.112B | 0.00 |
MSP Recovery (LIFW) | United States | $0.111B | 0.00 |
SHL Telemedicine (SHLT) | Israel | $0.079B | 0.00 |
Future Health ESG (FHLT) | United States | $0.068B | 0.00 |
Mobile-health Network Solutions (MNDR) | Singapore | $0.067B | 0.00 |
Augmedix (AUGX) | United States | $0.060B | 0.00 |
EUDA Health Holdings (EUDA) | Singapore | $0.057B | 0.00 |
HeartBeam (BEAT) | United States | $0.056B | 0.00 |
Zepp Health (ZEPP) | China | $0.052B | 0.00 |
Movano (MOVE) | United States | $0.043B | 0.00 |
CareCloud (CCLD) | United States | $0.040B | 0.00 |
Akili (AKLI) | United States | $0.034B | 0.00 |
ImmunoPrecise Antibodies (IPA) | Canada | $0.029B | 0.00 |
Bullfrog AI Holdings (BFRG) | United States | $0.023B | 0.00 |
Streamline Health Solutions (STRM) | United States | $0.020B | 0.00 |
Cue Health (HLTH) | United States | $0.019B | 0.00 |
Strata Skin Sciences (SSKN) | United States | $0.013B | 0.00 |
Syra Health (SYRA) | United States | $0.011B | 0.00 |
Biotricity (BTCY) | United States | $0.010B | 0.00 |
Transgenomic (PRPO) | United States | $0.009B | 0.00 |
HeartSciences (HSCS) | United States | $0.007B | 0.00 |
Predictive Oncology (POAI) | United States | $0.007B | 0.00 |
Healthcare Triangle (HCTI) | United States | $0.004B | 0.00 |
Zhongchao (ZCMD) | China | $0.003B | 0.00 |
Tivic Health Systems (TIVC) | United States | $0.001B | 0.00 |
Centogene (CNTG) | Germany | $0.000B | 0.00 |
MDxHealth SA (MDXH) | Belgium | $0.000B | 0.00 |
Nyxoah SA (NYXH) | Belgium | $0.000B | 0.00 |